Two linked articles have just been published in Vox Sanguinis showing that dependence on US Plasma can be offset by publicly collected plasma, which may be converted into PDMPs under contracts that return the products to the public health system. Achieving strategic independence in PDMPs can result in economic benefits and protects the supply of these products from the vagaries of the commercial market.
SUPPLY’s impact continues
